About the Campaign
There is an urgent need for patient led research initiatives to create a better understanding of patients with rare neurological diseases.
Your contribution will help to provide funding for clinical assessments and a robust natural history which will assist in preparation for clinical trials of patients with pathogenic variants on the MEF2C gene.
Your involvement is critical to our mission to accelerate treatments for our patients, and to create synergies within the rare neurological disease arena.
We are grateful for your support!
Dr. Wendy K. Chung, Chief of Pediatrics, Boston Children's Hospital, and Mary Ellen Avery Professor at Harvard University
Our Patients
Support a Fundraiser
Campaign Activity
See who supports your cause and what they have to say about it!